Large-scale testing (Phase 3)Study completedNCT00224484
What this trial is testing
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
Who this might be right for
Herpes Simplex
GlaxoSmithKline 5,960